0.05Open0.08Pre Close2 Volume47 Open Interest70.00Strike Price10.00Turnover60.32%IV11.58%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0257Delta0.0120Gamma1582.30Leverage Ratio-0.0304Theta-0.0002Rho-40.71Eff Leverage0.0050Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet